Pay in 4 interest-free payments of $25.50 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
an effect that is reduced by central administration of the 5-HT1A receptor antagonist spiroxatrine
CTL killing function significantly increases following antibody blockade of CLL inhibitory ligands or Lenalidomide treatment compared to control treatments
Formula: C10H9NO2
1186/s12858-016-0066-9
1246529-32-7
Valproic acid - CAS# 99-66-1 Size:Solid 2 mg an effect that is reducedAI 10 49 is an inhibitor that binds the transcription factor fusion CBF SMMHC. AI 10 49, that selectively binds to CBF SMMHC and disrupts its binding to RUNX1. AI 10 49 restores RUNX1 transcriptional activity, displays favorable pharmacokinetics, and delays leukemia progression in mice. Treatment of primary inv(16) AML patient blasts with AI 10 49 triggers selective cell death. These data suggest that direct inhibition of the oncogenic CBF SMMHC
US$ 115.70
US$ 514.78
US$ 25.60
US$ 181.48
US$ 1608.73
US$ 28.10
US$ 14.05
US$ 11.60
US$ 48.20
US$ 125.97